DVAX - Dynavax Technologies Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue32711,0434,050
Cost of Revenue---
Gross Profit32711,0434,050
Operating Expenses
Research Development64,98884,49386,943
Selling General and Administrative27,36737,25722,180
Non Recurring2,7832,7832,783
Total Operating Expenses96,332--
Operating Income or Loss-96,005-110,707-105,073
Income from Continuing Operations
Total Other Income/Expenses Net851-1,737-1,149
Earnings Before Interest and Taxes-95,154-112,444-104,551
Interest Expense--572
Income Before Tax-95,154-112,444-105,123
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-95,154-112,444-106,794
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-95,154-112,444-106,794
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-95,154-112,444-106,794